These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9324641)

  • 1. Thalidomide for aphthous ulcers in HIV infection.
    Birnkrant D
    N Engl J Med; 1997 Oct; 337(15):1086-7. PubMed ID: 9324641
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of thalidomide in HIV infection.
    Taiwo BO
    AIDS Read; 2001 Oct; 11(10):511-3, 518-9, 523-4. PubMed ID: 11708084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide effective for oral ulcers.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide for severe aphthous ulceration in patients with human immunodeficiency virus (HIV) infection.
    Oldfield EC
    Am J Gastroenterol; 1994 Dec; 89(12):2276-7. PubMed ID: 7977265
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in oral aphthous ulceration in patients with HIV infection.
    Henriquet F; Roy MT; Repetto T; Fusco F
    Palliat Med; 1994; 8(3):255-6. PubMed ID: 7952375
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
    Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
    J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and HIV: several possible uses.
    Smith D
    AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of thalidomide against esophageal ulceration in HIV infection].
    Bodokh I; Lacour JP; Rainero C; Castanet J; Michiels JF; Ortonne JP
    Presse Med; 1993 Sep; 22(26):1233. PubMed ID: 8248047
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide and wasting.
    Posit Aware; 1995; VI(6):5. PubMed ID: 11363147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aphthous ulcers in HIV-infected patients: treatment with thalidomide.
    Strazzi S; Lebbe C; Geoffray C; Ablon G; Morel P; Verola O; Molina JM
    Genitourin Med; 1992 Dec; 68(6):424-5. PubMed ID: 1487271
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.
    Shetty K
    Spec Care Dentist; 2005; 25(5):236-41. PubMed ID: 16454100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.
    Paterson DL; Georghiou PR; Allworth AM; Kemp RJ
    Clin Infect Dis; 1995 Feb; 20(2):250-4. PubMed ID: 7742424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus.
    Weidle PJ
    Am J Health Syst Pharm; 1996 Feb; 53(4):368, 371-2, 378. PubMed ID: 8673657
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide effective treatment for AIDS-related mouth ulcers.
    Randall P
    NIAID AIDS Agenda; 1995 Dec; ():2. PubMed ID: 11363350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of major oral aphthous ulcers in HIV-1 infection after highly active antiretroviral therapy.
    Alegre M; Dalmau J; Domingo P; Roé E; Alomar A
    Int J Infect Dis; 2007 May; 11(3):278-9. PubMed ID: 16857406
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thalidomide, the treatment of choice in aphthae in HIV infection].
    Samson J; Kuffer R; Radeff B
    Presse Med; 1990 Apr; 19(15):722. PubMed ID: 2139969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.